Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
NATCOPHARM Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
High ROE but declining trend
High operating margin but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
NATCOPHARM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
NATCOPHARM Bulk, Block & Insider Trades
NATCOPHARM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Stock split(1 : 5)Nominal value change from INR 10 to INR 2. Ex-date: 26th Nov 2015 Announced on: 12th Aug 2015
Company Profile
Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with a focus on research and development. It develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. Its ... Read More
Key personnel
Shri. Venkaiah Chowdary NannapaneniD
Chairman of the Board, Managing Director, Executive Director
Sri. Rajeev NannapaneniD
Chief Executive Officer, Vice Chairman of the Board, Executive Director
Mr. S. V. V. N. Appa Rao
Chief Financial Officer
Dr. Linga Rao DonthineniD
President - Technical Affairs, Executive Director
Mr. Amit Parekh
Chief Financial Officer
Sri. Potluri Sivaramakrishna PrasadD
Executive Vice President - Corporate Engineering Services, Executive Director
